The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDrax Regulatory News (DRX)

Share Price Information for Drax (DRX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 555.00
Bid: 567.00
Ask: 568.50
Change: -15.00 (-2.63%)
Spread: 1.50 (0.265%)
Open: 569.00
High: 571.50
Low: 555.00
Prev. Close: 570.00
DRX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2022 Performance Awards - EPS Condition

19 Apr 2022 12:00

RNS Number : 5995I
Drax Group PLC
19 April 2022
 

19 April 2022

Drax Group plc

("Drax" or the "Group"; Symbol:DRX)

 

2022 Performance Awards - EPS Condition

At the time of publishing the annual report for the financial year ended 31 December 2021, Drax advised it would be separately determining, and thereafter releasing details of, the Cumulative Adjusted Earnings per Share performance condition which applies to grants made to PDMRs and other employees in the 2022 financial year.

The vesting of awards granted are subject to satisfying two performance criteria over the financial years 2022, 2023 and 2024. 50% of the awards will be measured based on Relative Total Shareholder Return relative to the FTSE-350, and the remaining 50% will be measured based on Cumulative Adjusted Earnings per Share.

Following a meeting of the Remuneration Committee, the proposed Cumulative Adjusted EPS target for 2022 has been agreed. The EPS target was set after considering the company's internal forecasts, market expectations and sector peers.

 

 

Threshold

Target

Maximum

239.5p

266.1p

292.7p

 

 

BASIS OF VESTING

Performance

Target

% of Award Vesting(of EPS performance condition)

Below threshold

0%

Threshold

239.5p

25%

Maximum

292.7p

100%

 

Vesting between the threshold and maximum will be on a straight-line basis.

The EPS target is 'Adjusted EPS', derived from Adjusted Results as reported in the Company's audited financial statements. Instances where such adjustments might apply include acquisition and restructuring costs, asset obsolescence charges and certain remeasurements on derivative contracts.

There may arise circumstances during the performance period where adjustment or discretion is applied by the Remuneration Committee by reference to exceptional items and the Remuneration Policy. The application of such adjustments would be considered during and upon completion of the performance cycle. In making their assessment, the Remuneration Committee will take into account appropriate advice (for example from our auditors, Remuneration Committee advisers or the Audit Committee) and also give due consideration to the shareholder experience. The Remuneration Committee would also take into account exceptional and unforeseen circumstances, including wider considerations such as the prevailing market environment, in assessing the appropriate level of vesting judged against the performance of the Company and management at the end of the performance period.

Total Shareholder Return relative to the FTSE-350 will be measured over the three-year period (2022-2024) consistent with the approach previously approved by shareholders.

The Remuneration Committee of Drax considers that attaining outturn at the top end of the range would represent strong performance considering the uncertain economic circumstances and the challenges to the broader economy. 

 

Ends

 

Enquiries:

Drax Investor Relations: Mark Strafford

mark.strafford@drax.com 

+44 (0) 7730 763 949

Brett Gladden, Group Company Secretarybrett.gladden@drax.com+44 (0)7936 362586

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSFEFSUEESEEL
Date   Source Headline
22nd Apr 202012:45 pmRNSResult of AGM
22nd Apr 20209:00 amRNSHolding(s) in Company
22nd Apr 20207:00 amRNSTrading Update
17th Apr 20209:00 amRNSDirector/PDMR Shareholding
15th Apr 20207:06 amRNSNotice of AGM
9th Apr 20204:28 pmRNSAdditional Listing
8th Apr 20207:00 amRNSDirectorate Change
6th Apr 20204:29 pmRNSRemuneration Policy 2020 – EPS Condition
6th Apr 202011:53 amRNSBlock listing Interim Review - Bonus Matching Plan
6th Apr 202011:51 amRNSBlock listing Interim Review - Sharesave Plan
3rd Apr 20203:35 pmRNSDirector/PDMR Shareholding
1st Apr 20209:00 amRNSDirector/PDMR Shareholding
1st Apr 20208:00 amRNSTotal Voting Rights
30th Mar 20204:12 pmRNSDirector/PDMR Shareholding
27th Mar 20203:18 pmRNSHolding(s) in Company
24th Mar 20203:19 pmRNSHolding(s) in Company
19th Mar 20209:00 amRNSNotice of AGM
10th Mar 20204:26 pmRNSHolding(s) in Company
9th Mar 20207:00 amRNSCapacity Market agreements for existing assets
2nd Mar 20205:15 pmRNSHolding(s) in Company
2nd Mar 202010:51 amRNSTotal Voting Rights
27th Feb 20207:00 amRNSAnnual Financial Report
27th Feb 20207:00 amRNSEnd of Coal Generation at Drax Power Station
19th Feb 20207:00 amRNSNOTICE OF FULL YEAR RESULTS ANNOUNCEMENT
6th Feb 20203:13 pmRNSHolding(s) in Company
4th Feb 20205:05 pmRNSHolding(s) in Company
3rd Feb 202010:19 amRNSTotal Voting Rights
3rd Feb 20207:00 amRNSCapacity Market Agreements
2nd Jan 202011:34 amRNSTotal Voting Rights
16th Dec 201910:02 amRNSNotice of Change to Director Details
10th Dec 20195:53 pmRNSHolding(s) in Company
2nd Dec 201910:01 amRNSTotal Voting Rights
29th Nov 20192:45 pmRNSHolding(s) in Company
19th Nov 20197:00 amRNSCapital Markets Day; Trading Update
13th Nov 20193:34 pmRNSHolding(s) in Company
6th Nov 20191:47 pmRNSHolding(s) in Company
1st Nov 201912:14 pmRNSTotal Voting Rights
24th Oct 201912:09 pmRNSReapproval of UK Capacity Market
15th Oct 20199:01 amRNSHolding(s) in Company
14th Oct 20195:38 pmRNSHolding(s) in Company
11th Oct 20199:00 amRNSDirector/PDMR Shareholding
1st Oct 20193:34 pmRNSBlock listing Interim Review - Sharesave scheme
1st Oct 20193:29 pmRNSBlock listing Interim Review - Bonus Matching Plan
1st Oct 201910:11 amRNSTotal Voting Rights
27th Sep 20197:00 amRNSDirectorate Change
23rd Sep 20194:15 pmRNSHolding(s) in Company
19th Sep 20198:40 amRNSNotice of Change to Director Details
10th Sep 20192:30 pmRNSHolding(s) in Company
2nd Sep 201912:04 pmRNSTotal Voting Rights
20th Aug 20192:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.